To investigate the possibility of developing biomarkers for hcc prognosis and companion diagnostics by using advanced sequencing technologies (ngs) and the data analysis algorithms for a set of target biomarkers.
Euripides2 will cover the electronic systems integration value chain, from materials, equipment and technologies, through components, modules, up to embedded, mechatronics, enmeshed and implanted systems.
Development of 100 femtosecond laser based ultra-precision manufacturing process and system to increase production yield rate for next generation display "smart amoled (active matrix active matrix organic light emitting)" - flexible, foldable, transparent, wearable, and sensor integrated
Therabodc aims at discovery of specific antibody fragments targeting g protein coupled receptors up regulated in tumor cells. The 2nd step is conjugating several anti-cancer drugs to the discovered antibody fragments. The 3rd is validating efficacy of combined molecules in cellular and animal model.